Fundz

KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer

TAKEN PRIVATEOct 06, 2025

Position

Chief People Officer

Company

KalVista Pharmaceuticals

Linea Aspesi
laspesi@kalvista.com
CambridgeBiotechnologyHealth Careresearch

Description

KalVista Pharmaceuticals has announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025. Both executives bring extensive experience to their respective roles and are expected to enhance the company's operational and human resources strategies.

Quick answer

KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer (October 6, 2025). KalVista Pharmaceuticals is based in Cambridge, Massachusetts, United States.

Who is the new Chief People Officer at KalVista Pharmaceuticals?
KalVista Pharmaceuticals named Linea Aspesi Chief People Officer, announced October 6, 2025.
What did KalVista Pharmaceuticals announce on October 6, 2025?
KalVista Pharmaceuticals has announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025. Both executives bring extensive experience to their respective roles and are expected to enhance the company's operational and human resources strategies.
What does KalVista Pharmaceuticals do?
KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need.
Where is KalVista Pharmaceuticals based?
KalVista Pharmaceuticals is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Quotient Therapeutics (October 2, 2025), Climb Bio, Inc. (October 1, 2025), Symeres (October 1, 2025) and Tessellate Bio (October 1, 2025) also announced leadership changes within 45 days of KalVista Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at KalVista Pharmaceuticals, and when

A new leader at KalVista Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day KalVista Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at KalVista Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at KalVista Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

KalVista Pharmaceuticals

Location

200 Crossing Blvd

Cambridge, Massachusetts, United States

About

KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need. KalVista is developing sebetralstat as an oral on-demand therapy for HAE attacks and has achieved its enrollment target for the phase 3 KONFIDENT clinical trial. In addition, KalVista’s oral Factor XIIa inhibitor program represents a new generation of therapies that may further improve the treatment for people living with HAE and other diseases. For more information about KalVista, please visit www.kalvista.com. For more information on the sebetralstat HAE on-demand Phase 3 KONFIDENT study, please visit www.konfidentstudy.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment KalVista Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nicole
Likely contact at this company
••••••••@••••••••

See Nicole's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for KalVista Pharmaceuticals's next move

Learn about Strategic plan

KalVista Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.